Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (181-190 of 186) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 186 results.
Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2015
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 StudyMiguel Martín, Amparo Ruiz Simón, Manuel Ruiz Borrego, et al.
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Journal of the National Cancer Institute|May 29, 2008
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancerMiguel Martín, Alvaro Rodríguez-Lescure, Amparo Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)Ana Lluch, Carlos H Barrios, Laura Torrecillas, et al.
Plos One|May 12, 2011
A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 geneMaider Ibarrola-Villava, Lara P Fernandez, Santos Alonso, et al.
Pageof 19

Showing results (181-190 of 186) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 186 results.
Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2015
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 StudyMiguel Martín, Amparo Ruiz Simón, Manuel Ruiz Borrego, et al.
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Journal of the National Cancer Institute|May 29, 2008
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancerMiguel Martín, Alvaro Rodríguez-Lescure, Amparo Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)Ana Lluch, Carlos H Barrios, Laura Torrecillas, et al.
Plos One|May 12, 2011
A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 geneMaider Ibarrola-Villava, Lara P Fernandez, Santos Alonso, et al.
Pageof 19